Zalicus, Inc.
5Patents
5Active
5Granted
45Portfolio score
Filing activity: Feb 15, 2006 → Nov 28, 2011 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8080553B2 | Methods and reagents for the treatment of immunoinflammatory disorders | Human Necessities | 54 | Active |
| US8475804B2 | Compositions and methods for treatment of filovirus-mediated diseases | Human Necessities | 11 | Active |
| US8067433B2 | Methods, compositions, and kits for the treatment of ophthalmic disorders | Emerging Cross-Sectional Technologies | 5 | Active |
| US8258153B2 | Methods, compositions, and kits for the treatment of ophthalmic disorders | Emerging Cross-Sectional Technologies | 4 | Active |
| US7915265B2 | Combinations for the treatment of immunoinflammatory disorders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.